Literature DB >> 32479989

Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.

Lu Zhao1, Liang Peng1, Danyi Yang1, Shi Chen1, Zhixin Lan1, Xuejing Zhu1, Shuguang Yuan1, Guochun Chen1, Yu Liu1, Hong Liu2.   

Abstract

BACKGROUND: Immunoglobulin A nephropathy (IgAN nephropathy, IgAN) is named for the renal pathological features of IgA-dominant immunoglobulin deposition. IgA deposits, however, may also occur in other diseases, from liver disease and inflammation to chronic infections and tumors. Now increasing studies have suggested that galactose-deficient IgA1 (Gd-IgA1) plays a critical role in the pathogenesis of IgAN. This study aims to investigate whether the Gd-IgA1-specific antibody KM55 contributes to differentiating primary IgAN from other diseases with IgA deposits.
METHODS: In this retrospective study, we enrolled 100 Chinese patients with IgA deposits in renal biopsies, including IgAN(n = 40), IgAN with hepatitis B virus antigen deposits(n = 14), IgA vasculitis(n = 16), lupus nephritis(n = 11), incidental IgA deposits(n = 13) and negative controls(n = 6). Double immunostaining of Gd-IgA1 and IgA was performed in all biopsies.
RESULTS: There were similar patterns of Gd-IgA1 deposition in primary IgAN, IgA vasculitis, and IgAN with hepatitis B virus antigen deposits. Gd-IgA1 staining could also be seen in patients with lupus nephritis and incidental IgA deposits, but the intensity was significantly lower than IgAN, and the optimal cutoff was 2+ staining for differential diagnosis. Every increase in KM55 staining intensity of 1+ was associated with an increase in the odds of primary IgAN (OR: 4.399; 95% CI: 1.725-11.216).
CONCLUSIONS: Immunostaining for Gd-IgA1 by KM55 is not specific for IgA nephropathy, but weak or negative staining may favor incidental IgA deposits.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Galactose-deficient IgA1; Hepatitis B virus; IgA; IgA nephropathy; IgA vasculitis; Renal biopsy

Mesh:

Substances:

Year:  2020        PMID: 32479989     DOI: 10.1016/j.clim.2020.108483

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  11 in total

1.  Oxidative stress and macrophage infiltration in IgA nephropathy.

Authors:  Yasar Caliskan; Erol Demir; Ecem Karatay; Yasemin Ozluk; Safak Mirioglu; Ahmet Burak Dirim; Ayse Serra Artan; Sebahat Usta Akgul; Ozgur Akin Oto; Fatma Savran Oguz; Aydin Turkmen; Krista L Lentine; Halil Yazici
Journal:  J Nephrol       Date:  2021-11-16       Impact factor: 3.902

2.  Immunoglobulin A Glycosylation and Its Role in Disease.

Authors:  Alyssa L Hansen; Colin Reily; Jan Novak; Matthew B Renfrow
Journal:  Exp Suppl       Date:  2021

Review 3.  Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don't Know.

Authors:  Yukako Ohyama; Matthew B Renfrow; Jan Novak; Kazuo Takahashi
Journal:  J Clin Med       Date:  2021-08-05       Impact factor: 4.241

4.  Utility of glomerular Gd-IgA1 staining for indistinguishable cases of IgA nephropathy or Alport syndrome.

Authors:  Shinya Ishiko; Akihito Tanaka; Asami Takeda; Masayuki Hara; Naoto Hamano; Masahiro Koizumi; Toshinori Ueno; Hiroki Hayashi; Atsushi Kondo; Sadayuki Nagai; Yuya Aoto; Nana Sakakibara; China Nagano; Tomoko Horinouchi; Tomohiko Yamamura; Takeshi Ninchoji; Yuko Shima; Koichi Nakanishi; Norishige Yoshikawa; Kazumoto Iijima; Kandai Nozu
Journal:  Clin Exp Nephrol       Date:  2021-03-20       Impact factor: 2.801

Review 5.  IgA vasculitis with nephritis: update of pathogenesis with clinical implications.

Authors:  M Colleen Hastings; Dana V Rizk; Krzysztof Kiryluk; Raoul Nelson; Rima S Zahr; Jan Novak; Robert J Wyatt
Journal:  Pediatr Nephrol       Date:  2021-04-05       Impact factor: 3.651

6.  Sofosbuvir and ledipasvir decreased nephrotic syndrome caused by IgA nephropathy with a membranoproliferative pattern of injury in hepatitis C virus-induced cirrhosis: a case report.

Authors:  Xiaohao Zhang; Jing Zhou; Canming Li; Jialing Rao; Yuanqing Li; Jun Zhang; Hui Peng
Journal:  Ann Transl Med       Date:  2022-04

7.  Comprehensive analysis of circRNA expression profiles and circRNA-associated competing endogenous RNA networks in IgA nephropathy.

Authors:  Haiyang Liu; Di Liu; Yexin Liu; Ming Xia; Yan Li; Mei Li; Hong Liu
Journal:  PeerJ       Date:  2020-12-03       Impact factor: 2.984

Review 8.  Glomerulonephritis with severe nephrotic syndrome induced by immune complexes composed of galactose-deficient IgA1 in primary Sjögren's syndrome: a case report.

Authors:  Ryo Nishioka; Satoshi Hara; Hiroyuki Kawahara; Kiyoaki Ito; Ichiro Mizushima; Masayoshi Hirata; Michio Nagata; Mitsuhiro Kawano
Journal:  BMC Nephrol       Date:  2021-03-25       Impact factor: 2.388

Review 9.  Pathogenesis of IgA Vasculitis: An Up-To-Date Review.

Authors:  Yan Song; Xiaohan Huang; Guizhen Yu; Jianjun Qiao; Jun Cheng; Jianyong Wu; Jianghua Chen
Journal:  Front Immunol       Date:  2021-11-09       Impact factor: 7.561

10.  Triptolide promotes autophagy to inhibit mesangial cell proliferation in IgA nephropathy via the CARD9/p38 MAPK pathway.

Authors:  Lu Zhao; Zhixin Lan; Liang Peng; Lili Wan; Di Liu; Xia Tan; Chengyuan Tang; Guochun Chen; Hong Liu
Journal:  Cell Prolif       Date:  2022-06-22       Impact factor: 8.755

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.